Literature DB >> 26614115

Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion.

Alkim Oden Akman1,2, Ozge Basaran3, Derya Ozyoruk4, Unsal Han5, Tulin Sayli6, Nilgun Cakar3.   

Abstract

UNLABELLED: Castleman disease (CD) is a rare poorly understood lymphoproliferative disorder. Pediatric onset CD has been reported before. However, most of them have benign unicentric pattern. Multicentric CD (MCD) is quite rare in children. Herein, we report a 13-year-old adolescent boy with MCD of the hyaline vascular variant presenting with pleural and pericardial effusion, which is an uncommon presentation.
CONCLUSION: MCD should be considered in the differential diagnosis of pleural and/or pericardial effusion with unexplained lymph nodes in children. What is Known •Pediatric Castleman disease (CD) most commonly occurs in the unicentric form, which typically is asymptomatic and cured by lymph node excision. •The diagnosis of MCD can be difficult owing to the heterogeneity of presentation and potential for nonspecific multisystem involvement. What is New •A 13-year-old adolescent boy was diagnosed with MCD of the hyaline vascular variant presenting with pleural and pericardial effusion, which is an uncommon presentation. •In a pediatric patient with fever, pleural-pericardial effusion and multiple lymph nodes, MCD should be considered in differantial diagnosis.

Entities:  

Keywords:  Castleman disease; Children; Pericardial effusion; Pleural effusion

Mesh:

Year:  2015        PMID: 26614115     DOI: 10.1007/s00431-015-2674-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot.

Authors:  B CASTLEMAN; V W TOWNE
Journal:  N Engl J Med       Date:  1954-09-02       Impact factor: 91.245

2.  Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

Authors:  Yasufumi Masaki; Akio Nakajima; Haruka Iwao; Nozomu Kurose; Tomomi Sato; Takuji Nakamura; Miyuki Miki; Tomoyuki Sakai; Takafumi Kawanami; Toshioki Sawaki; Yoshimasa Fujita; Masao Tanaka; Toshihiro Fukushima; Toshiro Okazaki; Hisanori Umehara
Journal:  J Clin Exp Hematop       Date:  2013

3.  Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).

Authors:  Hiroshi Kawabata; Kazue Takai; Masaru Kojima; Naoya Nakamura; Sadao Aoki; Shigeo Nakamura; Tomohiro Kinoshita; Yasufumi Masaki
Journal:  J Clin Exp Hematop       Date:  2013

Review 4.  Castleman's disease in childhood: report of three cases and review of the literature.

Authors:  Piero Farruggia; Antonino Trizzino; Nunzia Scibetta; Giovanni Cecchetto; Patrizia Guerrieri; Emanuele S G D'Amore; Paolo D'Angelo
Journal:  Ital J Pediatr       Date:  2011-10-20       Impact factor: 2.638

5.  Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease.

Authors:  Frits van Rhee; Luis Fayad; Peter Voorhees; Richard Furman; Sagar Lonial; Hossein Borghaei; Lubomir Sokol; Julie Crawford; Mark Cornfeld; Ming Qi; Xiang Qin; Jennifer Herring; Corey Casper; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

Review 6.  Multicentric Castleman disease presenting with fever.

Authors:  Christiana Smith; Cathy Lee-Miller; Megan K Dishop; Carrye Cost; Michael Wang; Edwin J Asturias
Journal:  J Pediatr       Date:  2014-10-01       Impact factor: 4.406

Review 7.  Diagnosis and management of Castleman disease.

Authors:  Jacob D Soumerai; Aliyah R Sohani; Jeremy S Abramson
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

Review 8.  Paediatric Castleman disease: report of seven cases and review of the literature.

Authors:  N Parez; B Bader-Meunier; C C Roy; J P Dommergues
Journal:  Eur J Pediatr       Date:  1999-08       Impact factor: 3.183

9.  Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases.

Authors:  M Kojima; N Nakamura; N Tsukamoto; A Yokohama; H Itoh; S Kobayashi; M Kashimura; N Masawa; S Nakamura
Journal:  Lupus       Date:  2010-10-21       Impact factor: 2.911

10.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.